Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
The phase I study is to determine the maximum tolerated dose and dose limiting toxicity of
docetaxel and nedaplatin prescribed twice weekly in combination with concurrent chest
radiotherapy in patients with locally advanced esophageal squamous cell carcinoma.